Qian, X., et al. (2025). Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα ...

Fatty acid oxidation disorders (FAODs) comprise more than 20 defects in mitochondrial β-oxidation and fatty acid transport and are inherited in an autosomal recessive pattern. 1,2 Newborn testing ...

Laure Allenbach, Yves Poirier, Analysis of the Alternative Pathways for the β-Oxidation of Unsaturated Fatty Acids Using Transgenic Plants Synthesizing Polyhydroxyalkanoates in Peroxisomes, Plant ...

The U.S. Food and Drug Administration (FDA) approved Dojolvi on June 30, 2020 as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed ...

A New Drug Application (NDA) has been submitted to the Food and Drug Administration (FDA) for triheptanoin (Ultragenyx) for the treatment of long-chain fatty acid oxidation disorders.

Laurence Moire, Enea Rezzonico, Simon Goepfert, Yves Poirier, Impact of Unusual Fatty Acid Synthesis on Futile Cycling through β-Oxidation and on Gene Expression in Transgenic Plants, Plant Physiology ...

The Food and Drug Administration (FDA) has approved Dojolvi™ (triheptanoin; Ultragenyx) as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly ...